Announcing the Launch of The Association of Diversity in Clinical Trials

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Announcing the Launch of The Association of Diversity in Clinical Trials

PR Newswire

DALLAS, Feb. 3, 2023 /PRNewswire/ -- The Association of Diversity in Clinical Trials (AOD) is being launched and introduced at upcoming industry conferences SCOPE and the Health Equity in Clinical Trials Congress this month. The AOD will become the first entity to represent industry in an effort to meet new government and regulatory demands in the field of diversity.

The mission of the organization is to bring industry leaders together to establish much needed standards and best practices related to improving the representation of diverse participants in clinical trials. This will be achieved through the development, integration, and monitoring of quality and consistent diversity methodology across the research industry. 

Dr. Jerome Adams, Chairman of the Board of the AOD and former US Surgeon General stated, "there is no time like the present to take action on behalf of industry to develop standards, GCPs, and practices to guide and establish direction in this rapidly growing area of importance.  Being involved in this groundbreaking step forward, is critical to the path towards progress for participants of diverse backgrounds."

Dr. Diana Foster, who will share her significant experience in leading many initiatives in diversity believes, "the changing face of clinical trials will require a collaborative vision for change to be executed across the clinical trial spectrum. This will require consensus at a high level and the development of actionable standards to move the needle."

A prestigious Advisory Board of leaders will be announced soon who will support this unprecedented step towards the assurance of representative diversity and inclusion in clinical trials.

Diana Foster, Ph.D.
The Association of Diversity in Clinical Trials
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/announcing-the-launch-of-the-association-of-diversity-in-clinical-trials-301738073.html

SOURCE The Association of Diversity in Clinical Trials

Copyright CNW Group 2023

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).